| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Poster Number | Participant Type | Title | First Name | Last Name | Title of the abstract | |||||||||||||||||
2 | 1 | Students | Dr. | Graham | Erwin | Recurrent repeat expansions in human cancer genomes | |||||||||||||||||
3 | 2 | Faculty and Other Delegates | Dr. | Rama Krishna | Kancha | Analysis of tumour-intrinsic genetic alterations in immune-related genes reveals variable frequencies in solid cancers and sub-types | |||||||||||||||||
4 | 3 | Students | Ms. | Shweta | Subhedar | The cancer research databases | |||||||||||||||||
5 | 4 | Students | Mrs. | Honey | Pavithran | Therapeutic Role of Cardiac Glycosides in Breast cancer: An Integrative study using Transcriptome Analysis, In-vitro cell culture model, and Molecular Docking | |||||||||||||||||
6 | 5 | Students | Mr. | BALAJI | AK | Lamin A/C – EZH2 interaction represses mesenchymal transcription factors in breast cancer cells | |||||||||||||||||
7 | 6 | Students | Mr. | SHOUVIK | CHAKRAVARTY | Molecular genomic signatures reveal tumor evolution dynamics in multi-regionally sampled Indian gingivobuccal oral cancer biopsies | |||||||||||||||||
8 | 7 | Students | Ms. | Anjitha | Nair | Nuclear lamins modulate DNA damage response during cell migration | |||||||||||||||||
9 | 8 | Students | Mr. | Arif | Najar | The Role of Androgen Receptor upon Activation of Estrogen Signaling in Luminal ER+ Breast Cancer | |||||||||||||||||
10 | 9 | Students | Mr. | Harshavardhan | BV | 4 states ≠ 4 dimension: Neural-progenitor-like – Mesenchymal antagonism dominates the patterns of phenotypic heterogeneity in Glioblastoma | |||||||||||||||||
11 | 10 | Students | Ms. | CHANDRAKALA | M | Circulating tumor DNA detection as a liquid biopsy tool to monitor breast cancer disease progression | |||||||||||||||||
12 | 11 | Students | Ms. | Pooja | Suryavanshi | Cellulose-alginate scaffold: a standalone 3D cancer model | |||||||||||||||||
13 | 12 | Students | Ms. | ASHITA | GADWAL | Identification of potential key genes and their regulatory microRNAs in lymph node and skin metastasis in breast cancer using in silico analysis. | |||||||||||||||||
14 | 13 | Students | Mr. | Bhavesh | Neekhra | FedTree: Federated Learning on Gene Expression Data | |||||||||||||||||
15 | 14 | Students | Mr. | Santam | Saha | Unravelling the role of the nucleolar protein Fibrillarin in cancer progression | |||||||||||||||||
16 | 15 | Students | Mrs. | Jyoti | Rani | Identification of Key Human Genes and Pathways Targeted by Human Papillomavirus E5 oncoprotein in Cervical Cancer: An in-silico Approach | |||||||||||||||||
17 | 16 | Industry | Mrs. | Suchithra | V | Use of Structured Real-World Oncology Data to Enhance Clinical Trial Recruitment | |||||||||||||||||
18 | 17 | Students | Ms. | Apoorva | D | Detection of circulating miRNAs: emerging liquid biopsy-based genomics in cancer | |||||||||||||||||
19 | 18 | Students | Mr. | Swapnil | Kumar | Decoding different subtypes of breast cancer using integrative network analysis | |||||||||||||||||
20 | 19 | Students | Ms. | Firdaus | Fatima | PhytoCAT: A Phytochemical data repository for Cancer potential Affordable Therapeutics | |||||||||||||||||
21 | 20 | Students | Ms. | Surabhi | Seth | Identifying perturbed pathways through integrated approach in Type 2 Diabetes associated Pancreatic cancer | |||||||||||||||||
22 | 21 | Students | Ms. | Jayati | Khanna | Uncovering mechanisms of lamin-dependent nuclear mechanotransduction in cancer cells | |||||||||||||||||
23 | 22 | Students | Ms. | Trishala | Das | Detecting clonal heterogeneity in breast cancer cell line, MCF-7 | |||||||||||||||||
24 | 23 | Faculty and Other Delegates | Mr. | Kunal | Tembhare | Multi-omics Data Integration based on Supervised Machine Learning Approaches: A case study using breast cancer samples | |||||||||||||||||
25 | 24 | Students | Mr. | Amol | Chaudhary | Investigating the Therapeutic Potential of Matairesinol against Triple-Negative Breast Cancer: Integrated Network Pharmacology and Bioinformatic Analytics Approach | |||||||||||||||||
26 | 25 | Faculty and Other Delegates | Dr. | Manu | Aryan | Protein lipidation as a target against tumorigenicity and therapy resistance of breast cancers | |||||||||||||||||
27 | 26 | Students | Ms. | Prajakta | Patil | Evaluating the Potential of Anti-Cancer Lignans in Rewiring Lipid Metabolism Reprogramming in Breast Cancer: A Computational Approach | |||||||||||||||||
28 | 27 | Students | Ms. | Rama | Rajadnya | Exploring the Multi-Target Therapeutic Potential of Matairesinol in Metastatic Prostate Cancer: A Network Pharmacology and Molecular Docking Investigation | |||||||||||||||||
29 | 28 | Students | Mr. | Asish Kumar | Swain | Single-cell transcriptome analysis identifies novel biomarkers involved in major liver cancer subtypes | |||||||||||||||||
30 | 28 | Faculty and Other Delegates | Dr. | Pankaj | Yadav | Single‐cell transcriptome analysis identifies novel biomarkers involved in major liver cancer subtypes | |||||||||||||||||
31 | 29 | Faculty and Other Delegates | Dr. | Ananda | Mukherjee | Targeting Transcriptional Addiction in Endometrial Cancer Cells | |||||||||||||||||
32 | 30 | Students | Ms. | Akansha | Srivastava | Deciphering Metabolic Heterogeneity in Endometrial Cancer: A Systems-Level Approach | |||||||||||||||||
33 | 31 | Students | Ms. | Shirani | Punniyamoorthy | Elucidating The Role of NonO (Non-POU Domain Containing Octamer-Binding) Protein in Breast Cancer Pathogenesis | |||||||||||||||||
34 | 32 | Industry | Dr. | Avinash | Mishra | Machine Learning Approach to Detect & Design Peptide Inhibitor Against PD1 and PD-L1 | |||||||||||||||||
35 | 33 | Students | Ms. | Britika | Roy | Highlighting Fragmentomics and Epigenetic Biomarkers regarding Hepatocellular Carcinoma | |||||||||||||||||
36 | 34 | Students | Ms. | Madhura | Joshi | Withania somnifera (L.) Dunal modulates Epithelial to Mesenchymal Transition in Cancer Metastasis: An In-silico Network Pharmacology Approach | |||||||||||||||||
37 | 35 | Students | Ms. | Juwayria | Sami | Spatial Transcriptomics to investigate Tumor Immune Microenvironment in Cancer patients | |||||||||||||||||
38 | 36 | Students | Dr. | Aishwarya | Dhadge | ‘Nanotheranostics’: Novel approach to tackle Head and Neck Cancers | |||||||||||||||||
39 | 37 | Students | Ms. | Khushi | Salvi | YAP function in growth factor receptor signalling in mammary epithelial cells during growth control and tumorigenesis. | |||||||||||||||||
40 | 38 | Students | Dr. | Pradnya | Bhale | Evaluation of Serum Magnesium levels in Oral Squamous Cell Carcinoma: A Systemic Review | |||||||||||||||||
41 | 39 | Students | Dr. | Himali | Pachpande | Estimation of Serum Vitamin B2 levels in Oral Squamous Cell Carcinoma Patients: A case-control study | |||||||||||||||||
42 | 40 | Students | Ms. | Gomathi | Venkatasubramanian | Prognostic significance of Yes associated protein-1 (YAP1) in molecular subtypes of an Indian cohort of breast cancer patients | |||||||||||||||||
43 | 41 | Students | Ms. | Ishika | Jain | Identification of metabolic inhibitory potential of certain phytochemicals by in silico methods | |||||||||||||||||
44 | 42 | Faculty and Other Delegates | Dr. | Sanchitha | Chandar | Establishing quality control measures for collection of clinical specimen in a low resource setting for high throughput molecular analysis of oral potentially malignant disorders | |||||||||||||||||
45 | 43 | Students | Ms. | Amrita | Ulhe | Network pharmacology prediction and molecular docking based strategy to explore epigenetic targets of ALA against cervical cancer | |||||||||||||||||
46 | 44 | Students | Mr. | Priyam | Chatterjee | Correlation of HER2 overexpression and genomic amplification in HER2-positive cells with the expression levels of nuclear proteins. | |||||||||||||||||
47 | 45 | Faculty and Other Delegates | Dr. | Vivek | Tiwari//Neha Yadav | Radiogenomics in Gliomas: Fractality and Lacunarity of Glioma Components as a Marker of IDH and MGMT Molecular Status | |||||||||||||||||
48 | 46 | Students | Mrs. | HIMA | P K | Anti-Diabetic Drug Repaglinide Induced down-regulation of multiple epigenetic regulators in human cancer cell lines | |||||||||||||||||
49 | 47 | Students | Mrs. | Aswathy | Kunnummal | The Cytotoxic and Pro-Apoptotic Effects of a Novel Trypsin Inhibitor from Caesalpinia sappan L. (CsTI) on Human Lung Cancer | |||||||||||||||||
50 | 48 | Faculty and Other Delegates | Dr. | Aastha | Aggarwal | Breaking Down Silos: Data Linkages and Cancer Research in India | |||||||||||||||||
51 | 49 | Students | Mr. | Tanmoy | Bandopadhyay | Detection And Validation of ERBB2/HER2 Genomic Amplification In Breast Cancer Cells Using Fluorescence In Situ Hybridization (FISH) | |||||||||||||||||
52 | 50 | Faculty and Other Delegates | Dr. | Divya | Khanna | PATEINT DERIVED ORGANOIDS (PDOs) – clinically relevant drug screening models | |||||||||||||||||
53 | 51 | Students | Ms. | Durgesh | Meena | Unravelling the Innate Immune Signaling in Glioblastoma Tumor Microenvironment | |||||||||||||||||
54 | 52 | Students | Ms. | Sushmita | Rajkhowa | Cross-talk of Glial NLRs in Glioblastoma Pathophysiology | |||||||||||||||||
55 | 53 | Faculty and Other Delegates | Dr. | Thekkekara Devassy | Babu | Unresolved endoplasmic reticulum stress (ERS) promotes the activation of PERK/ATF4/NRF2 survival pathway in colon cancer | |||||||||||||||||
56 | 54 | Students | Mr. | Ankit | Mohanty | Phenotypic heterogeneity of Glioma subcomponents is Distinctive of Genotypic status | |||||||||||||||||
57 | 55 | Students | Mr. | Vedant | Ingawale | Investigating the correlation between Collagen Deposition in Breast Tumour Microenvironment for association with Stages and Survival Outcomes | |||||||||||||||||
58 | 56 | Students | Dr. | Hari | Prasad | An inside job: how endosomal Na+/H+ exchanger 9 regulates invasion and metastasis of colorectal cancer | |||||||||||||||||
59 | 57 | Students | Dr. | BIJAYLAXMI | SAHOO | Integrating Genetic and Metabolic Profiling to Unravel Glioma Heterogeneity and Prognosis | |||||||||||||||||
60 | 58 | Students | Mr. | Bhavesh | Vasave | Investigation of regulation of YAP driven tumorigenesis by PPP using in breast FFPE tissues | |||||||||||||||||
61 | 59 | Students | Dr. | John Kandam Kulathu | Mathew | Elucidating anticancer potential of Cleistanthin A on colorectal cancer cells. | |||||||||||||||||
62 | 60 | Faculty and Other Delegates | Dr. | Aruna | Korlimarla | A novel multianalyte signature for stratifying Indian Non-Muscle Invasive Bladder Cancer – A single center observational study | |||||||||||||||||
63 | 61 | Faculty and Other Delegates | Ms. | Pranali | Kanase | Prashanti Cancer Care Mission's (PCCM) FFPE and Fresh Frozen Tumor Tissue Biobank: Advancing Breast Cancer Research in India | |||||||||||||||||
64 | 62 | Faculty and Other Delegates | Ms. | Jisha | John | Determining the germline mutational profile of breast cancer patients and its clinicopathological correlations – A single institutional study | |||||||||||||||||
65 | 63 | Faculty and Other Delegates | Dr. | Namrata | Athavale | Enhancing Clinical Data Granularity in a Single Surgeon Surgical Oncology Unit: Implementing Swasthya AI for Live Data Capture | |||||||||||||||||
66 | 64 | Students | Mr. | Hemant Kumar | Joon | Machine learning and functional genomics aided integrative approach to identify prognostic signatures for lung squamous cell carcinoma | |||||||||||||||||
67 | 65 | Faculty and Other Delegates | Dr. | Thenmozhi | Panneerselavam | Database on the medicinal plants in Siddha system of medicine for Cancer palliative care | |||||||||||||||||
68 | 66 | Students | Ms. | Nidhi | Sharma | Cervical Cancer Therapeutics: In Silico Molecular Docking of HMKaq Phytochemicals Against HPV16E6 Oncoprotein and MD Studies | |||||||||||||||||
69 | 67 | Students | Mrs. | Sangeetha | Muthamilselvan | Mining of signal biomarkers and multi-omic validation of cascade classifier for early-stage breast cancer subtyping | |||||||||||||||||
70 | 68 | Students | Ms. | AVANTIKA | AGRAWAL | Dissection of building blocks of HPV-positive and HPV-negative head and neck squamous cell carcinoma | |||||||||||||||||
71 | 69 | Students | Mr. | Nidharshan | Sundar Raj | Clustering of Androgen Receptor Bound Enhancers Mediate Prostate Cancer Progression | |||||||||||||||||
72 | 70 | Students | Mr. | Kanaka Sai Ram | Padam | Interplay of mutant and HOX genes in the head and neck squamous cell carcinoma | |||||||||||||||||
73 | 71 | Students | Mr. | Snijesh | V P | The Enigmatic Glucocorticoid Receptor (GR): A Dual Role Player in Hormone-Regulated Cancers | |||||||||||||||||
74 | |||||||||||||||||||||||
75 | |||||||||||||||||||||||
76 | |||||||||||||||||||||||
77 | |||||||||||||||||||||||
78 | |||||||||||||||||||||||
79 | |||||||||||||||||||||||
80 | |||||||||||||||||||||||
81 | |||||||||||||||||||||||
82 | |||||||||||||||||||||||
83 | |||||||||||||||||||||||
84 | |||||||||||||||||||||||
85 | |||||||||||||||||||||||
86 | |||||||||||||||||||||||
87 | |||||||||||||||||||||||
88 | |||||||||||||||||||||||
89 | |||||||||||||||||||||||
90 | |||||||||||||||||||||||
91 | |||||||||||||||||||||||
92 | |||||||||||||||||||||||
93 | |||||||||||||||||||||||
94 | |||||||||||||||||||||||
95 | |||||||||||||||||||||||
96 | |||||||||||||||||||||||
97 | |||||||||||||||||||||||
98 | |||||||||||||||||||||||
99 | |||||||||||||||||||||||
100 |